MG
GSK icon

Mather Group’s GSK GSK Stock Holding History

Mather Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.3K Buy
+1,274
New +$69K ﹤0.01% 977
2025
Q4 		– Sell
-755
Closed -$32.6K – 1053
2025
Q3 		$32.6K Buy
+755
New +$29.5K ﹤0.01% 1007
2025
Q2 		– Sell
-425
Closed -$16.5K – 1063
2025
Q1 		$16.5K Buy
425
+133
+46% +$4.87K ﹤0.01% 1134
2024
Q4 		$9.88K Sell
292
-436
-60% -$15.7K ﹤0.01% 1251
2024
Q3 		$29.7K Buy
728
+185
+34% +$7.57K ﹤0.01% 978
2024
Q2 		$23.3K Buy
543
+305
+128% +$12.8K ﹤0.01% 1233
2024
Q1 		$8.82K Buy
+238
New +$9.81K ﹤0.01% 1231

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return